| Dopamine synthesis capacity in patients with treatment-resistant schizophrenia A Demjaha, RM Murray, PK McGuire, S Kapur, OD Howes American Journal of Psychiatry 169 (11), 1203-1210, 2012 | 441 | 2012 |
| Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function A Demjaha, A Egerton, RM Murray, S Kapur, OD Howes, JM Stone, ... Biological psychiatry 75 (5), e11-e13, 2014 | 422 | 2014 |
| Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors A Demjaha, JM Lappin, D Stahl, MX Patel, JH MacCabe, OD Howes, ... Psychological medicine 47 (11), 1981-1989, 2017 | 341 | 2017 |
| Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses J Lally, O Ajnakina, M Di Forti, A Trotta, A Demjaha, A Kolliakou, ... Psychological medicine 46 (15), 3231-3240, 2016 | 341 | 2016 |
| Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations J Zanelli, A Reichenberg, K Morgan, P Fearon, E Kravariti, P Dazzan, ... American Journal of Psychiatry 167 (1), 78-85, 2010 | 277 | 2010 |
| Disorganization/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis A Demjaha, L Valmaggia, D Stahl, M Byrne, P McGuire Schizophrenia bulletin 38 (2), 351-359, 2012 | 249 | 2012 |
| How genes and environmental factors determine the different neurodevelopmental trajectories of schizophrenia and bipolar disorder A Demjaha, JH MacCabe, RM Murray Schizophrenia bulletin 38 (2), 209-214, 2012 | 217 | 2012 |
| Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11? A Demjaha, K Morgan, C Morgan, S Landau, K Dean, A Reichenberg, ... Psychological medicine 39 (12), 1943-1955, 2009 | 172 | 2009 |
| Self-harm in first-episode psychosis SB Harvey, K Dean, C Morgan, E Walsh, A Demjaha, P Dazzan, ... The British Journal of Psychiatry 192 (3), 178-184, 2008 | 170 | 2008 |
| The test–retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function A Egerton, A Demjaha, P McGuire, MA Mehta, OD Howes Neuroimage 50 (2), 524-531, 2010 | 134 | 2010 |
| Aggressive behaviour at first contact with services: findings from the AESOP First Episode Psychosis Study K Dean, E Walsh, C Morgan, A Demjaha, P Dazzan, K Morgan, T Lloyd, ... Psychological medicine 37 (4), 547-557, 2007 | 134 | 2007 |
| Association of age, antipsychotic medication, and symptom severity in schizophrenia with proton magnetic resonance spectroscopy brain glutamate level: a mega-analysis of … K Merritt, PK McGuire, A Egerton, A Aleman, W Block, OJN Bloemen, ... JAMA psychiatry 78 (6), 667-681, 2021 | 128 | 2021 |
| Dopaminergic Function in the Psychosis Spectrum: An [18F]-DOPA Imaging Study in Healthy Individuals With Auditory Hallucinations OD Howes, P Shotbolt, M Bloomfield, K Daalman, A Demjaha, ... Schizophrenia bulletin 39 (4), 807-814, 2013 | 116 | 2013 |
| Association between symptom dimensions and categorical diagnoses of psychosis: a cross-sectional and longitudinal investigation M Russo, SZ Levine, A Demjaha, M Di Forti, S Bonaccorso, P Fearon, ... Schizophrenia bulletin 40 (1), 111-119, 2014 | 102 | 2014 |
| Interaction testing and polygenic risk scoring to estimate the association of common genetic variants with treatment resistance in schizophrenia AF Pardiñas, SE Smart, IR Willcocks, PA Holmans, CA Dennison, ... JAMA psychiatry 79 (3), 260-269, 2022 | 100 | 2022 |
| Natural Language Processing markers in first episode psychosis and people at clinical high-risk SE Morgan, K Diederen, PE Vértes, SHY Ip, B Wang, B Thompson, ... Translational psychiatry 11 (1), 630, 2021 | 95 | 2021 |
| Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis K Merritt, RA McCutcheon, A Aleman, S Ashley, K Beck, W Block, ... Molecular psychiatry 28 (5), 2039-2048, 2023 | 77 | 2023 |
| Lower speech connectedness linked to incidence of psychosis in people at clinical high risk TJ Spencer, B Thompson, D Oliver, K Diederen, A Demjaha, S Weinstein, ... Schizophrenia research 228, 493-501, 2021 | 75 | 2021 |
| Opposite effects of catechol-O-methyltransferase Val158Met on cortical function in healthy subjects and patients with schizophrenia DP Prata, A Mechelli, CHY Fu, M Picchioni, F Kane, S Kalidindi, ... Biological psychiatry 65 (6), 473-480, 2009 | 75 | 2009 |
| A potential biomarker for treatment stratification in psychosis: evaluation of an [18F] FDOPA PET imaging approach M Veronese, B Santangelo, S Jauhar, E D’Ambrosio, A Demjaha, ... Neuropsychopharmacology 46 (6), 1122-1132, 2021 | 67 | 2021 |
P.B. JonesProfessor of Psychiatry, University of CambridgeVerified email at cam.ac.uk
